Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078156 · ClinicalTrials.gov registry record · Phase 3
Women's Treatment for Trauma and Substance Use Disorders - 1
A Phase 3 study of Substance-Related Disorders, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 409
- Enrollment target
- 7
- Study locations
NCT00078156: Completed Phase 3 study of Substance-Related Disorders, sponsored by New York State Psychiatric Institute.
NCT00078156 is a Phase 3 study of Substance-Related Disorders that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 409 participants, below the 1,514-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (73% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00078156, a Phase 3 study of Substance-Related Disorders, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 409 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to compare the effectiveness of adding Seeking Safety to standard substance abuse treatment to adding a control condition: Women's Health Education to standard substance abuse treatment.
Conditions Studied
Interventions
- BEHAVIORAL Behavior Therapy
Study Locations (7)
Florida
- Gateway Community Services - Jacksonville
- The Villiage - Miami
New York
- Addiction Research & Treatment Corp.-MSUCAS - Brooklyn
- Addiction Research & Treatment Corp.-RISE - Brooklyn
Ohio
- Maryhaven, Inc. - Columbus
South Carolina
- Charleston Center - Charleston
Washington
- Residence XII - Kirkland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2004-01 |
| Est. Completion | 2005-10 |
| Phase | Phase 3 |
What the finished NCT00078156 record still lists
NCT00078156 is an interventional study that assigns participants to a tested intervention. The registered 409 participants enrollment target is mid-sized for trials with a published cap, below the 1,514-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Behavior Therapy is the first listed.
NCT00078156 lists 7 locations in 5 states (Florida, New York, Ohio).
Frequently Asked Questions
What is clinical trial NCT00078156 about?
NCT00078156 is a clinical study titled "Women's Treatment for Trauma and Substance Use Disorders - 1". The purpose of this study is to compare the effectiveness of adding Seeking Safety to standard substance abuse treatment to adding a control condition: Women's Health Education to standard substance abuse treatment.
What is the current status of trial NCT00078156?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 409 participants. The study started on 2004-01. Estimated completion is 2005-10.
What conditions does trial NCT00078156 study?
This clinical trial studies the following conditions: Substance-Related Disorders.
What interventions are being tested in trial NCT00078156?
The interventions under investigation include: Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00078156?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00078156 being conducted?
This trial has 7 study locations across Florida, New York, Ohio, South Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00078156's enrollment target sits among peer trials
409 11th of 58 higher than 48 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
ACTIVE NOT RECRUITING · Phase 3
-
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
COMPLETED · Phase 3
-
Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders
COMPLETED · Phase 3
-
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
COMPLETED · Phase 3
-
Job-Seekers Training for Patients With Drug Dependence - 1
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06717334 · 409 participants
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia